Global Radiopharmaceuticals Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 110

Published Date: 18 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

According to our (Global Info Research) latest study, the global Radiopharmaceuticals market size was valued at USD 6956.7 million in 2022 and is forecast to a readjusted size of USD 11660 million by 2029 with a CAGR of 7.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.

This report is a detailed and comprehensive analysis for global Radiopharmaceuticals market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Radiopharmaceuticals market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Radiopharmaceuticals market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Radiopharmaceuticals market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Radiopharmaceuticals market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Radiopharmaceuticals
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Radiopharmaceuticals market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bracco Imaging, Bayer, Mallinckrodt, Nordion and Triad Isotopes, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Radiopharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Diagnostic Radioisotopes
Therapeutic Radioisotopes

Market segment by Application
Oncology
Cardiology
Other

Major players covered
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Radiopharmaceuticals, with price, sales, revenue and global market share of Radiopharmaceuticals from 2018 to 2023.
Chapter 3, the Radiopharmaceuticals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Radiopharmaceuticals.
Chapter 14 and 15, to describe Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Radiopharmaceuticals
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Radiopharmaceuticals Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Diagnostic Radioisotopes
        1.3.3 Therapeutic Radioisotopes
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Radiopharmaceuticals Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Oncology
        1.4.3 Cardiology
        1.4.4 Other
    1.5 Global Radiopharmaceuticals Market Size & Forecast
        1.5.1 Global Radiopharmaceuticals Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Radiopharmaceuticals Sales Quantity (2018-2029)
        1.5.3 Global Radiopharmaceuticals Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Bracco Imaging
        2.1.1 Bracco Imaging Details
        2.1.2 Bracco Imaging Major Business
        2.1.3 Bracco Imaging Radiopharmaceuticals Product and Services
        2.1.4 Bracco Imaging Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Bracco Imaging Recent Developments/Updates
    2.2 Bayer
        2.2.1 Bayer Details
        2.2.2 Bayer Major Business
        2.2.3 Bayer Radiopharmaceuticals Product and Services
        2.2.4 Bayer Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Bayer Recent Developments/Updates
    2.3 Mallinckrodt
        2.3.1 Mallinckrodt Details
        2.3.2 Mallinckrodt Major Business
        2.3.3 Mallinckrodt Radiopharmaceuticals Product and Services
        2.3.4 Mallinckrodt Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Mallinckrodt Recent Developments/Updates
    2.4 Nordion
        2.4.1 Nordion Details
        2.4.2 Nordion Major Business
        2.4.3 Nordion Radiopharmaceuticals Product and Services
        2.4.4 Nordion Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Nordion Recent Developments/Updates
    2.5 Triad Isotopes
        2.5.1 Triad Isotopes Details
        2.5.2 Triad Isotopes Major Business
        2.5.3 Triad Isotopes Radiopharmaceuticals Product and Services
        2.5.4 Triad Isotopes Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Triad Isotopes Recent Developments/Updates
    2.6 Lantheus
        2.6.1 Lantheus Details
        2.6.2 Lantheus Major Business
        2.6.3 Lantheus Radiopharmaceuticals Product and Services
        2.6.4 Lantheus Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Lantheus Recent Developments/Updates
    2.7 IBA Group
        2.7.1 IBA Group Details
        2.7.2 IBA Group Major Business
        2.7.3 IBA Group Radiopharmaceuticals Product and Services
        2.7.4 IBA Group Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 IBA Group Recent Developments/Updates
    2.8 GE Healthcare
        2.8.1 GE Healthcare Details
        2.8.2 GE Healthcare Major Business
        2.8.3 GE Healthcare Radiopharmaceuticals Product and Services
        2.8.4 GE Healthcare Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 GE Healthcare Recent Developments/Updates
    2.9 China Isotope & Radiation
        2.9.1 China Isotope & Radiation Details
        2.9.2 China Isotope & Radiation Major Business
        2.9.3 China Isotope & Radiation Radiopharmaceuticals Product and Services
        2.9.4 China Isotope & Radiation Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 China Isotope & Radiation Recent Developments/Updates
    2.10 Jubilant Pharma
        2.10.1 Jubilant Pharma Details
        2.10.2 Jubilant Pharma Major Business
        2.10.3 Jubilant Pharma Radiopharmaceuticals Product and Services
        2.10.4 Jubilant Pharma Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Jubilant Pharma Recent Developments/Updates
    2.11 Eli Lilly
        2.11.1 Eli Lilly Details
        2.11.2 Eli Lilly Major Business
        2.11.3 Eli Lilly Radiopharmaceuticals Product and Services
        2.11.4 Eli Lilly Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Eli Lilly Recent Developments/Updates
    2.12 Advanced Accelerator Applications
        2.12.1 Advanced Accelerator Applications Details
        2.12.2 Advanced Accelerator Applications Major Business
        2.12.3 Advanced Accelerator Applications Radiopharmaceuticals Product and Services
        2.12.4 Advanced Accelerator Applications Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Advanced Accelerator Applications Recent Developments/Updates
    2.13 SIEMENS
        2.13.1 SIEMENS Details
        2.13.2 SIEMENS Major Business
        2.13.3 SIEMENS Radiopharmaceuticals Product and Services
        2.13.4 SIEMENS Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 SIEMENS Recent Developments/Updates
    2.14 Dongcheng
        2.14.1 Dongcheng Details
        2.14.2 Dongcheng Major Business
        2.14.3 Dongcheng Radiopharmaceuticals Product and Services
        2.14.4 Dongcheng Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Dongcheng Recent Developments/Updates
    2.15 Navidea
        2.15.1 Navidea Details
        2.15.2 Navidea Major Business
        2.15.3 Navidea Radiopharmaceuticals Product and Services
        2.15.4 Navidea Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Navidea Recent Developments/Updates

3 Competitive Environment: Radiopharmaceuticals by Manufacturer
    3.1 Global Radiopharmaceuticals Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Radiopharmaceuticals Revenue by Manufacturer (2018-2023)
    3.3 Global Radiopharmaceuticals Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Radiopharmaceuticals Manufacturer Market Share in 2022
        3.4.2 Top 6 Radiopharmaceuticals Manufacturer Market Share in 2022
    3.5 Radiopharmaceuticals Market: Overall Company Footprint Analysis
        3.5.1 Radiopharmaceuticals Market: Region Footprint
        3.5.2 Radiopharmaceuticals Market: Company Product Type Footprint
        3.5.3 Radiopharmaceuticals Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Radiopharmaceuticals Market Size by Region
        4.1.1 Global Radiopharmaceuticals Sales Quantity by Region (2018-2029)
        4.1.2 Global Radiopharmaceuticals Consumption Value by Region (2018-2029)
        4.1.3 Global Radiopharmaceuticals Average Price by Region (2018-2029)
    4.2 North America Radiopharmaceuticals Consumption Value (2018-2029)
    4.3 Europe Radiopharmaceuticals Consumption Value (2018-2029)
    4.4 Asia-Pacific Radiopharmaceuticals Consumption Value (2018-2029)
    4.5 South America Radiopharmaceuticals Consumption Value (2018-2029)
    4.6 Middle East and Africa Radiopharmaceuticals Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Radiopharmaceuticals Sales Quantity by Type (2018-2029)
    5.2 Global Radiopharmaceuticals Consumption Value by Type (2018-2029)
    5.3 Global Radiopharmaceuticals Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Radiopharmaceuticals Sales Quantity by Application (2018-2029)
    6.2 Global Radiopharmaceuticals Consumption Value by Application (2018-2029)
    6.3 Global Radiopharmaceuticals Average Price by Application (2018-2029)

7 North America
    7.1 North America Radiopharmaceuticals Sales Quantity by Type (2018-2029)
    7.2 North America Radiopharmaceuticals Sales Quantity by Application (2018-2029)
    7.3 North America Radiopharmaceuticals Market Size by Country
        7.3.1 North America Radiopharmaceuticals Sales Quantity by Country (2018-2029)
        7.3.2 North America Radiopharmaceuticals Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Radiopharmaceuticals Sales Quantity by Type (2018-2029)
    8.2 Europe Radiopharmaceuticals Sales Quantity by Application (2018-2029)
    8.3 Europe Radiopharmaceuticals Market Size by Country
        8.3.1 Europe Radiopharmaceuticals Sales Quantity by Country (2018-2029)
        8.3.2 Europe Radiopharmaceuticals Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Radiopharmaceuticals Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Radiopharmaceuticals Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Radiopharmaceuticals Market Size by Region
        9.3.1 Asia-Pacific Radiopharmaceuticals Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Radiopharmaceuticals Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Radiopharmaceuticals Sales Quantity by Type (2018-2029)
    10.2 South America Radiopharmaceuticals Sales Quantity by Application (2018-2029)
    10.3 South America Radiopharmaceuticals Market Size by Country
        10.3.1 South America Radiopharmaceuticals Sales Quantity by Country (2018-2029)
        10.3.2 South America Radiopharmaceuticals Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Radiopharmaceuticals Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Radiopharmaceuticals Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Radiopharmaceuticals Market Size by Country
        11.3.1 Middle East & Africa Radiopharmaceuticals Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Radiopharmaceuticals Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Radiopharmaceuticals Market Drivers
    12.2 Radiopharmaceuticals Market Restraints
    12.3 Radiopharmaceuticals Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Radiopharmaceuticals and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Radiopharmaceuticals
    13.3 Radiopharmaceuticals Production Process
    13.4 Radiopharmaceuticals Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Radiopharmaceuticals Typical Distributors
    14.3 Radiopharmaceuticals Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Radiopharmaceuticals Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Radiopharmaceuticals Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Bracco Imaging Basic Information, Manufacturing Base and Competitors
    Table 4. Bracco Imaging Major Business
    Table 5. Bracco Imaging Radiopharmaceuticals Product and Services
    Table 6. Bracco Imaging Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Bracco Imaging Recent Developments/Updates
    Table 8. Bayer Basic Information, Manufacturing Base and Competitors
    Table 9. Bayer Major Business
    Table 10. Bayer Radiopharmaceuticals Product and Services
    Table 11. Bayer Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Bayer Recent Developments/Updates
    Table 13. Mallinckrodt Basic Information, Manufacturing Base and Competitors
    Table 14. Mallinckrodt Major Business
    Table 15. Mallinckrodt Radiopharmaceuticals Product and Services
    Table 16. Mallinckrodt Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Mallinckrodt Recent Developments/Updates
    Table 18. Nordion Basic Information, Manufacturing Base and Competitors
    Table 19. Nordion Major Business
    Table 20. Nordion Radiopharmaceuticals Product and Services
    Table 21. Nordion Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Nordion Recent Developments/Updates
    Table 23. Triad Isotopes Basic Information, Manufacturing Base and Competitors
    Table 24. Triad Isotopes Major Business
    Table 25. Triad Isotopes Radiopharmaceuticals Product and Services
    Table 26. Triad Isotopes Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Triad Isotopes Recent Developments/Updates
    Table 28. Lantheus Basic Information, Manufacturing Base and Competitors
    Table 29. Lantheus Major Business
    Table 30. Lantheus Radiopharmaceuticals Product and Services
    Table 31. Lantheus Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Lantheus Recent Developments/Updates
    Table 33. IBA Group Basic Information, Manufacturing Base and Competitors
    Table 34. IBA Group Major Business
    Table 35. IBA Group Radiopharmaceuticals Product and Services
    Table 36. IBA Group Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. IBA Group Recent Developments/Updates
    Table 38. GE Healthcare Basic Information, Manufacturing Base and Competitors
    Table 39. GE Healthcare Major Business
    Table 40. GE Healthcare Radiopharmaceuticals Product and Services
    Table 41. GE Healthcare Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. GE Healthcare Recent Developments/Updates
    Table 43. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
    Table 44. China Isotope & Radiation Major Business
    Table 45. China Isotope & Radiation Radiopharmaceuticals Product and Services
    Table 46. China Isotope & Radiation Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. China Isotope & Radiation Recent Developments/Updates
    Table 48. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
    Table 49. Jubilant Pharma Major Business
    Table 50. Jubilant Pharma Radiopharmaceuticals Product and Services
    Table 51. Jubilant Pharma Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Jubilant Pharma Recent Developments/Updates
    Table 53. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 54. Eli Lilly Major Business
    Table 55. Eli Lilly Radiopharmaceuticals Product and Services
    Table 56. Eli Lilly Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Eli Lilly Recent Developments/Updates
    Table 58. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
    Table 59. Advanced Accelerator Applications Major Business
    Table 60. Advanced Accelerator Applications Radiopharmaceuticals Product and Services
    Table 61. Advanced Accelerator Applications Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Advanced Accelerator Applications Recent Developments/Updates
    Table 63. SIEMENS Basic Information, Manufacturing Base and Competitors
    Table 64. SIEMENS Major Business
    Table 65. SIEMENS Radiopharmaceuticals Product and Services
    Table 66. SIEMENS Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. SIEMENS Recent Developments/Updates
    Table 68. Dongcheng Basic Information, Manufacturing Base and Competitors
    Table 69. Dongcheng Major Business
    Table 70. Dongcheng Radiopharmaceuticals Product and Services
    Table 71. Dongcheng Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Dongcheng Recent Developments/Updates
    Table 73. Navidea Basic Information, Manufacturing Base and Competitors
    Table 74. Navidea Major Business
    Table 75. Navidea Radiopharmaceuticals Product and Services
    Table 76. Navidea Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Navidea Recent Developments/Updates
    Table 78. Global Radiopharmaceuticals Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 79. Global Radiopharmaceuticals Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 80. Global Radiopharmaceuticals Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 81. Market Position of Manufacturers in Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 82. Head Office and Radiopharmaceuticals Production Site of Key Manufacturer
    Table 83. Radiopharmaceuticals Market: Company Product Type Footprint
    Table 84. Radiopharmaceuticals Market: Company Product Application Footprint
    Table 85. Radiopharmaceuticals New Market Entrants and Barriers to Market Entry
    Table 86. Radiopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
    Table 87. Global Radiopharmaceuticals Sales Quantity by Region (2018-2023) & (K Units)
    Table 88. Global Radiopharmaceuticals Sales Quantity by Region (2024-2029) & (K Units)
    Table 89. Global Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
    Table 90. Global Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
    Table 91. Global Radiopharmaceuticals Average Price by Region (2018-2023) & (USD/Unit)
    Table 92. Global Radiopharmaceuticals Average Price by Region (2024-2029) & (USD/Unit)
    Table 93. Global Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
    Table 94. Global Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
    Table 95. Global Radiopharmaceuticals Consumption Value by Type (2018-2023) & (USD Million)
    Table 96. Global Radiopharmaceuticals Consumption Value by Type (2024-2029) & (USD Million)
    Table 97. Global Radiopharmaceuticals Average Price by Type (2018-2023) & (USD/Unit)
    Table 98. Global Radiopharmaceuticals Average Price by Type (2024-2029) & (USD/Unit)
    Table 99. Global Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
    Table 100. Global Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
    Table 101. Global Radiopharmaceuticals Consumption Value by Application (2018-2023) & (USD Million)
    Table 102. Global Radiopharmaceuticals Consumption Value by Application (2024-2029) & (USD Million)
    Table 103. Global Radiopharmaceuticals Average Price by Application (2018-2023) & (USD/Unit)
    Table 104. Global Radiopharmaceuticals Average Price by Application (2024-2029) & (USD/Unit)
    Table 105. North America Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
    Table 106. North America Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
    Table 107. North America Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
    Table 108. North America Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
    Table 109. North America Radiopharmaceuticals Sales Quantity by Country (2018-2023) & (K Units)
    Table 110. North America Radiopharmaceuticals Sales Quantity by Country (2024-2029) & (K Units)
    Table 111. North America Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
    Table 112. North America Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
    Table 113. Europe Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
    Table 114. Europe Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
    Table 115. Europe Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
    Table 116. Europe Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
    Table 117. Europe Radiopharmaceuticals Sales Quantity by Country (2018-2023) & (K Units)
    Table 118. Europe Radiopharmaceuticals Sales Quantity by Country (2024-2029) & (K Units)
    Table 119. Europe Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
    Table 120. Europe Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
    Table 121. Asia-Pacific Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
    Table 122. Asia-Pacific Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
    Table 123. Asia-Pacific Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
    Table 124. Asia-Pacific Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
    Table 125. Asia-Pacific Radiopharmaceuticals Sales Quantity by Region (2018-2023) & (K Units)
    Table 126. Asia-Pacific Radiopharmaceuticals Sales Quantity by Region (2024-2029) & (K Units)
    Table 127. Asia-Pacific Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
    Table 128. Asia-Pacific Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
    Table 129. South America Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
    Table 130. South America Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
    Table 131. South America Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
    Table 132. South America Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
    Table 133. South America Radiopharmaceuticals Sales Quantity by Country (2018-2023) & (K Units)
    Table 134. South America Radiopharmaceuticals Sales Quantity by Country (2024-2029) & (K Units)
    Table 135. South America Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
    Table 136. South America Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
    Table 137. Middle East & Africa Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
    Table 138. Middle East & Africa Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
    Table 139. Middle East & Africa Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
    Table 140. Middle East & Africa Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
    Table 141. Middle East & Africa Radiopharmaceuticals Sales Quantity by Region (2018-2023) & (K Units)
    Table 142. Middle East & Africa Radiopharmaceuticals Sales Quantity by Region (2024-2029) & (K Units)
    Table 143. Middle East & Africa Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
    Table 144. Middle East & Africa Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
    Table 145. Radiopharmaceuticals Raw Material
    Table 146. Key Manufacturers of Radiopharmaceuticals Raw Materials
    Table 147. Radiopharmaceuticals Typical Distributors
    Table 148. Radiopharmaceuticals Typical Customers
List of Figures
    Figure 1. Radiopharmaceuticals Picture
    Figure 2. Global Radiopharmaceuticals Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Radiopharmaceuticals Consumption Value Market Share by Type in 2022
    Figure 4. Diagnostic Radioisotopes Examples
    Figure 5. Therapeutic Radioisotopes Examples
    Figure 6. Global Radiopharmaceuticals Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Radiopharmaceuticals Consumption Value Market Share by Application in 2022
    Figure 8. Oncology Examples
    Figure 9. Cardiology Examples
    Figure 10. Other Examples
    Figure 11. Global Radiopharmaceuticals Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Radiopharmaceuticals Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Radiopharmaceuticals Sales Quantity (2018-2029) & (K Units)
    Figure 14. Global Radiopharmaceuticals Average Price (2018-2029) & (USD/Unit)
    Figure 15. Global Radiopharmaceuticals Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Radiopharmaceuticals Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Radiopharmaceuticals by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Radiopharmaceuticals Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Radiopharmaceuticals Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Radiopharmaceuticals Average Price by Type (2018-2029) & (USD/Unit)
    Figure 30. Global Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Radiopharmaceuticals Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Radiopharmaceuticals Average Price by Application (2018-2029) & (USD/Unit)
    Figure 33. North America Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Radiopharmaceuticals Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Radiopharmaceuticals Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Radiopharmaceuticals Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Radiopharmaceuticals Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Radiopharmaceuticals Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Radiopharmaceuticals Market Drivers
    Figure 74. Radiopharmaceuticals Market Restraints
    Figure 75. Radiopharmaceuticals Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Radiopharmaceuticals in 2022
    Figure 78. Manufacturing Process Analysis of Radiopharmaceuticals
    Figure 79. Radiopharmaceuticals Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Radiopharmaceuticals market size was valued at USD 6956.7 million in 2023 and is forecast to a readjusted size of USD 11660 million by 2030 with a CAGR of 7.7% during review period.

Global Radiopharmaceuticals Supply, Demand and Key Producers, 2024-2030

Global Radiopharmaceuticals Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Pharma & Healthcare

The global Radiopharmaceuticals market size is expected to reach $ 11660 million by 2030, rising at a market growth of 7.7% CAGR during the forecast period (2024-2030).

Product Tags

Diagnostic Radiopharmaceuticals

Radiopharmaceuticals

Nuclear Medicine & Radiopharmaceuticals

Radiopharmaceuticals Dispensing Isolator

Radiopharmaceuticals in Nuclear Medical

Radiopharmaceuticals in Nuclear Medicine

PET Radiopharmaceuticals

Therapeutic Radiopharmaceuticals

Radiopharmaceuticals for Therapeutic

Diagnostic Radiopharmaceuticals & Contrast Media

SPECT Radiopharmaceuticals

SPECT and PET Radiopharmaceuticals

Cardiology Radiopharmaceuticals

Radiopharmaceuticals Dispensing System

Automatic Dispenser for Radiopharmaceuticals

Targeted Radiopharmaceuticals

PET Radioisotope (Radiopharmaceuticals in PET Imaging)

Radiopharmaceuticals for Diagnosis

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>